0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Bladder Tumors: - Molecular Aspects and Clinical Management (Paperback, 2011 ed.) Loot Price: R5,818
Discovery Miles 58 180
Bladder Tumors: - Molecular Aspects and Clinical Management (Paperback, 2011 ed.): Vinata B. Lokeshwar, Axel S. Merseburger,...

Bladder Tumors: - Molecular Aspects and Clinical Management (Paperback, 2011 ed.)

Vinata B. Lokeshwar, Axel S. Merseburger, Stefan H. Hautmann

Series: Cancer Drug Discovery and Development

 (sign in to rate)
Loot Price R5,818 Discovery Miles 58 180 | Repayment Terms: R545 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Bladder cancer is a common cancer of the urinary tract. It is the fourth leading cause of cancer-related death among men and the seventh among women. Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with respect to invasion and metastasis, frequent occurrence of new tumors in the bladder among patients treated with bladder preservation treatments and poor prognosis of patients with tumors that invade the bladder muscle and beyond. Due to these factors it has been said that the cost per patient of bladder cancer, from diagnosis to death is the highest of all cancers. In addition to it being a significant health problem, bladder cancer is an interesting cancer to study in many ways than one. For example, Environmental factors such as cigarette smoking and other carcinogens play a major role in the development of transitional carcinoma of the bladder, whereas, schitosomasis, a protozoan infection results in squamous cell carcinoma of the bladder. Different molecular pathways with distinct molecular signatures appear to be involved in the development of low-grade versus high-grade bladder tumors. Currently being monitored by an invasive endoscopic procedure, cystectomy, with urine cytology as an adjunct, bladder cancer is at the forefront of developing cancer biomarkers for non-invasive detection. Due to the differences in the invasive and metastatic potential of bladder tumors, treatment options differ depending upon tumor grade and stage. New advances are being made in treatment options to improve the outcome and quality of life for patients with bladder cancer. Similarly, new molecular nomograms are being discovered to predict treatment outcome so that individualized treatment options can be offered to patients.

General

Imprint: HumanaPress
Country of origin: United States
Series: Cancer Drug Discovery and Development
Release date: 2013
First published: 2011
Editors: Vinata B. Lokeshwar • Axel S. Merseburger • Stefan H. Hautmann
Dimensions: 235 x 155 x 25mm (L x W x T)
Format: Paperback
Pages: 468
Edition: 2011 ed.
ISBN-13: 978-1-61779-719-4
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-61779-719-7
Barcode: 9781617797194

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners